UK markets closed

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
7.980.00 (0.00%)
At close: 09:41PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
55,280
36,964
55,727
51,184
39,240
Cost of revenue
19,773
13,793
20,735
17,397
14,215
Gross profit
35,507
23,171
34,992
33,787
25,025
Operating expenses
Selling general and administrative
6,412
6,412
6,892
6,243
5,631
Total operating expenses
30,007
38,290
31,180
32,121
25,640
Operating income or loss
5,500
-15,119
3,812
1,667
-614.4395
Interest expense
50.2949
71
48
406
868
Income before tax
4,446
-14,846
3,828
248.2642
-1,477
Income tax expense
642.6744
-3,543
1,139
993.5295
-294.7336
Income from continuing operations
3,803
-11,303
2,689
-745.2653
-1,183
Net income
3,803
-11,303
2,689
-745.2369
-1,183
Net income available to common shareholders
3,803
-11,303
2,689
-745.2369
-1,183
Basic EPS
-0.09
-1.33
0.32
-0.09
-0.14
Diluted EPS
-0.09
-1.33
0.32
-0.09
-0.14
Basic average shares
8,500
8,500
8,500
8,500
8,500
Diluted average shares
8,500
8,500
8,500
8,500
8,500